This increase in TGF-α–induced phosphorylated (p-) Erk1/2 was significantly attenuated in IPF fibroblasts treated with ARRY compared with that in vehicle-treated controls (Supplemental Figure 3, A–C). Here, MAPK3 is linked to idiopathic pulmonary fibrosis.